In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - COG-ALTE11C2
Protocol Summary
- Protocol No
- COG-ALTE11C2
- Principal Investigator
- Richard Tower
- Phase
- N/A
- Title
- Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
- Associated Disease(s)
-
Osteosarcoma
- Description (Summary)
- The main purpose of this research study is to determine whether leukemia, lymphoma, or osteosarcoma patients treated with dexrazoxane have fewer markers for cardiac heart failure compared to those who do not receive dexrazoxane.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
